North American International Auto Show increases area business, including Medical Weight Loss Clinic


Detroit Free Press





“There’s definitely an increase, especially in our clinics around where auto executives live, Rochester, Birmingham, Dearborn,” President and Chief Operating Office David Paull said. “They talk with counselors about upcoming events, including Charity Preview. They want to look good for it and make sure they make healthy decisions while they’re there.”

Read the full story in the Detroit Free Press [more]


BBC News – Obesity ‘bad for brain’ by hastening cognitive decline

Carrying excess weight may impact on mental performance experts believe

Being overweight is not just bad for waistlines but for brains too, say researchers who have linked obesity to declining mental performance. Experts are not sure why this might be, but say metabolic changes such as high blood sugar and raised cholesterol are likely to be involved. Obesity has already been tipped as a risk factor for dementia. The work, published in Neurology, tracked the health of more than 6,000 British people over a decade.

The participants, who were aged between 35 and 55, took tests on memory and other cognitive skills three times over a 10-year period. People who were both obese and who had unhealthy metabolic changes showed a much faster decline on their cognitive test scores compared to others in the study.

Delving deeper

The experts stress that they only looked at cognitive function, not dementia. The boundary between normal ageing, mild cognitive impairment and dementia is blurred – not all impairment leads to dementia. All of the study participants came from one group of civil service workers, which may mean the findings may not apply more generally to other populations.

They said: “More research is needed to look at the effects of genetic factors and also to take into account how long people have been obese and how long they have had these metabolic risk factors and also to look at cognitive test scores spanning adulthood to give us a better understanding of the link between obesity and cognitive function, such as thinking, reasoning and memory.”

Shirley Cramer of the Alzheimer’s Research UK said: “We do not yet know why obesity and metabolic abnormality are linked to poorer brain performance, but with obesity levels on the rise, it will be important to delve a little deeper into this association.

“While the study itself focuses on cognitive decline, previous research suggests that a healthy diet, regular exercise, not smoking and controlling blood pressure and cholesterol in midlife can also help stave off dementia. With dementia figures spiralling towards a million, the findings suggest we should be conscious of our general health throughout life.”

via BBC News – Obesity ‘bad for brain’ by hastening cognitive decline.

Obesity in America

Obesity in America

Sitting is KILLING you – The truth about sitting down

Sitting is killing you

Sitting is killing you

Is junk food really cheaper?

Is junk food really cheaper

Is junk food really cheaper

Success Starts from the Inside

Medical Weight Loss Clinic - Success Starts from the Inside

Medical Weight Loss Clinic – Success Starts from the Inside

Belviq Diet Pill approved by the FDA to treat obese and overweight adults

The first FDA approved weight loss pill in 13 years


Southfield, MI – June 28, 2012:  On June 27, 2012, the U.S. Food and Drug Administration approved the weight loss pill Belviq (lorcaserin hydrochloride), to treat the approximately 1 in 3 obese and overweight adult Americans with a body mass index (BMI) of 30 or greater or overweight adults with a BMI of 27 or greater and who also have at least one weight-related medical condition such as type 2 diabetes, high blood pressure, or high cholesterol.

Belviq activates the serotonin 2C receptor in the brain.  This activation may help a person feel full after eating a small amount of food, thus eat less.  “This appetite suppressant seems to be of a higher standard compared to others that have been on the market” said Dr. Jerome Cooper, Medical Director of the Michigan-based Medical Weight Loss Clinic.

“There is a lack of weapons to fight obesity” stated Dr. Cooper, “Those of us that treat obesity would like as many weapons as possible at our disposal.”  Belviq will be the first FDA approved weight loss drug in over 13 years. The weight loss drugs fenfluramine and dexfenfluramine were pulled from the market in 1997 after evidence was discovered that they can cause heart valve damage. “Hopefully this drug proves to be successful not only in weight loss but also in maintaining weight loss,” said Dr. Cooper.

“There’s been three successful trials without major apparent side effects and with very successful weight loss”, said Dr. Cooper. Belviq was evaluated over a period of 104 weeks in three, placebo-controlled trials with nearly 8,000 obese and overweight patients with and without type 2 diabetes.  The trial also included lifestyle modification for participants that consisted of exercise counseling and a reduced calorie diet. About 38 percent of the patients with type 2 diabetes lost at least 5 percent of their body weight as did almost half of the patients without type 2 diabetes.  Participants that received the Belviq placebo experienced an average weight loss of 3 to 3.7 percent.  The approved labeling for Belviq will include a recommendation that the use of the drug be discontinued for patients who fail to lose 5 percent of their body weight after a 12 week treatment period. 

Echocardiography was used to asses heart valve function in the nearly 8,000 patients that participated in the evaluation. Statistically there was no significant difference in the development of valve abnormalities between Belviq and placebo-treated patients. It should be noted that Belviq has not been studied in patients with heart disease that have serious valvular problems.

The most common side effects of Belviq in non-diabetic patients are headache, dizziness, fatigue, nausea, dry mouth, and constipation, and in diabetic patients are low blood sugar (hypoglycemia), headache, back pain, cough, and fatigue.

About Medical Weight Loss Clinic (MWLC)

Medical Weight Loss Clinic is one of the largest established medically supervised weight loss programs in the Midwest.  It was founded in 1986 and has grown to over 30 corporately owned clinics throughout Michigan and across northern Ohio.  All Medical Weight Loss Clinic programs are customized based upon a patient’s medical profile and supervised by board certified doctors. Each patient receives one-on-one support from MWLC professionals with the focus of the weight loss program to help patients develop healthy and satisfying eating habits.  This year alone, Medical Weight Loss Clinic patients will lose in excess of two million pounds. For more information, go to